Charitable Pharmacies of America organization member receives Health Equity grant
Related Posts

Branson MO: My Neighbor’s Charitable Pharmacy (NCP) will open its doors at 1232 Branson Hills Parkway February of 2023

Federal/state grants are not the only gateways to funding. There are close to 750 “community foundations” nationwide which are public charities dedicated to improving the lives of people in a defined local geographic area.

Medication non-adherence has led to at least 100,000 preventable deaths each year and $100 billion annually in preventable healthcare costs in the United States

NOVA ScriptsCentral is excited to collaborate with the American Pharmacist Association to launch the “NOVA ScriptsCentral & American Pharmacist Association Safety-Net Health Equity Fellowship”.

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.

We estimate that if the PHE expires in April 2023, 18.0 million people will lose Medicaid coverage in the following…

Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost

NABP Associate Executive Director Josh Bolin on DSCSA compliance prior to FDA moving compliance deadline.

How a ‘weighted lottery’ helped underserved patients get a scarce Covid drug

The Outcomes of Implementing and Integrating Comprehensive Medication Management in Team-Based Care: A Review of the Evidence on Quality, Access and Costs, December 2023

Charitable Pharmacies of America organization member receives Health Equity grant

There are multiple factors that will impact an individual patient’s choice on how to go about getting their prescription medication. It can be overwhelming to navigate this complex issue.

How is a charitable pharmacy different from other types of pharmacies?

Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost

An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.